Patents by Inventor Michael P. Spuza
Michael P. Spuza has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20220233436Abstract: A method of regulating pain in a patient includes operations of measuring a patient pain level, determining a dose of ethanol which does not trigger alcohol intolerance or intoxication, delivering the dose of ethanol to the patient by inhalation from an active mesh nebulizer at a repeated interval, measuring the pain level of the patient at a monitoring interval, and determining, based on the patient pain level, whether to adjust the ethanol dose. The dose of ethanol is delivered in the form of particles of nebulized liquid having a diameter ranging from about 0.5 ?m to about 5.0 ?m, which are rapidly absorbed into the bloodstream of a patient and delivered to the brain.Type: ApplicationFiled: June 11, 2021Publication date: July 28, 2022Inventors: Donald M. PELL, Frank CAIAZZO, Michael P. SPUZA
-
Patent number: 11344686Abstract: A method of treating respiratory system tissue, includes operations of generating a plume of particles of a treating solution from a nebulizer, inhaling particles of the treating solution, delaying exhalation of an inhalation having particles of the treating solution therein, and determining whether a dose of the treating solution has been delivered, wherein the treating solution is a solution of at least 40% ethyl alcohol, by volume.Type: GrantFiled: July 23, 2020Date of Patent: May 31, 2022Assignee: BN INTELLECTUAL PROPERTIES, INC.Inventors: Donald M. Pell, Frank Caiazzo, Paula Pell, Govindan P. Nair, Michael P. Spuza
-
Publication number: 20210077753Abstract: A method of using a nebulizer includes connecting a medicine vial containing a medicine solution to the nebulizer and reading a medicine conductivity and/or pH value from the medicine vial. The conductivity and/or pH of the medicine solution is measured and compared with the medicine conductivity and/or pH value. When the medicine conductivity and/or pH value and the measured conductivity and/or pH of the medicine solution match, the flow rate value and dosage timings are read from the medicine vial; and the mesh is activated at the medicine flow rate value to produce a plume of particles of a medicine solution at the beginning of an inhalation. The active mesh is deactivated to stop making particles by manually or at a calculated time. The activation of the active mesh is restricted to approved users by means of an authentication code or biometric feature information.Type: ApplicationFiled: November 20, 2020Publication date: March 18, 2021Inventors: Donald M. PELL, Michael P. SPUZA, Govindan P. NAIR, Mark J. HOYT, Chad S FRAMPTON, Kent MABEY
-
Publication number: 20200353187Abstract: A method of treating respiratory system tissue, includes operations of generating a plume of particles of a treating solution from a nebulizer, inhaling particles of the treating solution, delaying exhalation of an inhalation having particles of the treating solution therein, and determining whether a dose of the treating solution has been delivered, wherein the treating solution is a solution of at least 40% ethyl alcohol, by volume.Type: ApplicationFiled: July 23, 2020Publication date: November 12, 2020Inventors: Donald M. Pell, Frank Caiazzo, Paula Pell, Govindan P. Nair, Michael P. Spuza
-
Patent number: 10729648Abstract: An active mesh nebulizer is used to generate a distribution of liquid particles or droplets having a diameter ranging from about 0.5 to about 5 micrometers (?m). Delivery and ingestion, by inhalation, of ethyl alcohol solution particles leads to rapid uptake of the alcohol solution by brain tissue, and avoids damage to the liver, gastrointestinal tract, and/or peripheral nervous system consistent with drinking ethyl alcohol. A brain effect of ethyl alcohol absorbed through alveoli in the lung occurs within less than 60 seconds, and body effects of alcohol consumption are reduced or eliminated. Delivery of ethyl alcohol to a user by absorption through alveoli provides a user with a brain effect while allowing tissue damage from drinking alcohol to heal. A lock out barcoded capsule containing ethyl alcohol, tethered to a smartphone application, prevents unauthorized use by non-designated users, or abuse by a designated user.Type: GrantFiled: December 21, 2018Date of Patent: August 4, 2020Assignee: BN INTELLECTUAL PROPERTIES, INC.Inventors: Donald M. Pell, Frank Caiazzo, Paula Pell, Govindan P. Nair, Michael P. Spuza, Nicholas A. Havercroft
-
Publication number: 20200197299Abstract: An active mesh nebulizer is used to generate a distribution of liquid particles or droplets having a diameter ranging from about 0.5 to about 5 micrometers (?m). Delivery and ingestion, by inhalation, of ethyl alcohol solution particles leads to rapid uptake of the alcohol solution by brain tissue, and avoids damage to the liver, gastrointestinal tract, and/or peripheral nervous system consistent with drinking ethyl alcohol. A brain effect of ethyl alcohol absorbed through alveoli in the lung occurs within less than 60 seconds, and body effects of alcohol consumption are reduced or eliminated. Delivery of ethyl alcohol to a user by absorption through alveoli provides a user with a brain effect while allowing tissue damage from drinking alcohol to heal. A lock out barcoded capsule containing ethyl alcohol, tethered to a smartphone application, prevents unauthorized use by non-designated users, or abuse by a designated user.Type: ApplicationFiled: December 21, 2018Publication date: June 25, 2020Inventors: Donald M. Pell, Frank Caiazzo, Paula Pell, Govindan P. Nair, Michael P. Spuza, Nicholas A. Havercroft
-
Publication number: 20180304031Abstract: A nebulizer comprising a nebulizing chamber with a vibrating mesh grid having a plurality of precision openings and said chamber with a liquid pharmaceutical product in a cartridge contacting the mesh grid for producing particle sizes of two (2) to four (4) microns; and an entrainment port for drawing air into the nebulizing chamber and through the grid. A control circuit, a source of electrical energy in said circuit such as two 1.5 volt lithium titanate batteries connected to said grid for producing vibration. A switch to turn said grid off and on and means for providing a first measured time period of four seconds for taking a first breath of air through the entrainment port and grid and through the thousands of passageways into the lungs and bloodstream of an individual. A second time period during which no vibration occurs. The grid is also self-cleaning as described.Type: ApplicationFiled: July 2, 2018Publication date: October 25, 2018Inventors: Nicholas A. Havercroft, Donald M. Pell, Michael P. Spuza, Govindan P. Nair
-
Publication number: 20180071274Abstract: In essence, the present invention relates to a medical product including between about 94% and about 98% of a saline solution, preferably a normal saline solution containing about 0.9% sodium chloride dissolved in water, about ?th of 1 milligram of relatively pure nicotine and about 3 milligrams of relatively pure nicotine. The medical product also includes about 1% and 3% of one or more flavors selected from the group consisting of citrus, tobacco, apple, cherry, maple, menthol, hazelnut, peach, lemon, vanilla and chocolate and 1% citric acid for taste. In addition, the medical product includes about 1% to 2% of ethyl alcohol for cleaning a micron mesh grid that generates particles of pure nicotine of from 2 to 5 microns that are drawn through an entrainment port, through a capsule containing the medical product through the micron mesh grid and into the individual's lungs and into their bloodstream.Type: ApplicationFiled: November 20, 2017Publication date: March 15, 2018Inventors: Nicholas A. Havercroft, Donald M. Pell, Michael P. Spuza, Govindan P. Nair
-
Publication number: 20180042912Abstract: In essence, the present invention relates to a medical product including between about 94% and about 98% of a saline solution, preferably a normal saline solution containing about 0.9% sodium chloride dissolved in water, about ?th of 1 milligram of relatively pure nicotine and about 3 milligrams of relatively pure nicotine. The medical product also includes about 1% and 3% of one or more flavors selected from the group consisting of citrus, tobacco, apple, cherry, maple, menthol, hazelnut, peach, lemon, vanilla and chocolate and 1% citric acid for taste. In addition, the medical product includes about 1% to 2% of ethyl alcohol for cleaning a micron mesh grid that generates particles of pure nicotine of from 2 to 5 microns that are drawn through an entrainment port, through a capsule containing the medical product through the micron mesh grid and into the individual's lungs and into their bloodstream.Type: ApplicationFiled: August 11, 2016Publication date: February 15, 2018Inventors: Nicholas A. Havercroft, Donald M. Pell, Michael P. Spuza, Govindan P. Nair
-
Publication number: 20170348495Abstract: A nebulizer in accordance with the present invention comprises a nebulizing chamber including a vibratable micro micron mesh grid having a plurality of precision openings and passageways therethrough disposed in said chamber with a liquid pharmaceutical product contained in said nebulizing cartridge and passing through said openings in said vibratable micro micron mesh grid for producing particle sizes of said pharmaceutical product of about two (2) to five (5) microns; and an entrainment port for drawing air into and through the entrainment port into the nebulizing chamber and through the grid. A control circuit, a source of electrical energy in said circuit such as two 1.5 volt nickel cadmium batteries connected to said grid for producing vibration.Type: ApplicationFiled: August 7, 2017Publication date: December 7, 2017Inventors: Nicholas A. Havercroft, Donald M. Pell, Michael P. Spuza, Govindan P. Nair
-
Publication number: 20170348494Abstract: A pulmonary delivery system includes an elongated body having an openable and closeable portion thereof for receiving an insertable and replaceable container such as a cartridge of pure medical product disposed in a saline solution. The medical product may be epinephrine, insulin or nicotine disposed in a saline solution. The system also incorporates a penetrating element that is disposed in the cylinder to pierce the cartridge and release the nicotine solution into the cylinder and into or on a micron mesh grid. A flow of air created by inhaling through a mouthpiece draws air into an individual's lungs from an entrainment port and onto a grid for atomizing a mist of micron droplets through the grid. It is recognized that the air from the entrainment port further dilutes the concentration of the medical product. The grid is connected to a source of electrical power to vibrate the mesh grid.Type: ApplicationFiled: June 6, 2016Publication date: December 7, 2017Inventors: Nicholas A. Havercroft, Donald M. Pell, Michael P. Spuza, Govindan P. Nair